Last reviewed · How we verify
Heated Lidocaine and Tetracaine Patch
At a glance
| Generic name | Heated Lidocaine and Tetracaine Patch |
|---|---|
| Also known as | Synera |
| Sponsor | ZARS Pharma Inc. |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Evaluation of the Depth and Duration of Anesthesia From Heated Lidocaine/Tetracaine (Synera®) Patches Compared With 5% Lidocaine (Lidoderm®) Patches Applied to Healthy Adult Volunteers (PHASE1)
- Study Evaluating Heated Lidocaine/Tetracaine Patch in Patients With Pain Associated With Myofascial Trigger Points (PHASE2)
- Study Evaluating a Heated Lidocaine and Tetracaine Topical Patch in the Treatment of Patients With Patellar Tendinopathy (PHASE2)
- Study Evaluating Heated Lidocaine/Tetracaine Topical Patch in Treatment of Patients With Shoulder Impingement Syndrome (PHASE2)
- Pain Patch Versus Injections in the Treatment of Pain Associated With Shoulder Impingement Syndrome (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Heated Lidocaine and Tetracaine Patch CI brief — competitive landscape report
- Heated Lidocaine and Tetracaine Patch updates RSS · CI watch RSS
- ZARS Pharma Inc. portfolio CI